These studies show cell-specific activation of inflammatory signaling pathways in response to CFH in the airspace and provide a foundation for future studies aimed at reducing CFH-dependent inflammation as a potential therapeutic intervention for patients with ARDS with elevated airspace CFH. The gene discussed is CFH; the disease is acute respiratory distress syndrome.